After Aphria deal, the new Tilray eyes transformation into a global cannabis brands giant

The company, which completed the deal on Monday, will have a market value in excess of US$8 billion, making it a giant in the fast-growing cannabis industry.

Simon, the founder and former CEO of tea and packaged-food company Hain Celestial, has the background to lead Tilray’s charge deeper into the consumer world.

In Canada, where we already have a 17 per cent to 18 per cent market share, my objective is to get to a 30 per cent share of the overall adult use market, and that’s going to be by selling adult use, medical products and cannabis 2.0 products, which are drinks and edibles.

We’ll look to do an acquisition in consumer packaged goods world that will help us parlay into recreational cannabis.

We think there are some big areas with CBD and CPG, like drinks.

The only thing I wouldn’t mix cannabis with is alcohol or tobacco.

I think cannabis should be regulated similarly to alcohol on the recreational side, and with regards to the medical side, it should be a pharmaceutical product, with prescriptions from your doctor.

We’re already expanding our medical cannabis into Spain, the U.K., France and are planning expansions into Israel and Poland.

I think companies like that will want to partner with someone like us, with great quality assurance, and great understanding of branding and products.

We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments.

This website uses cookies to personalize your content , and allows us to analyze our traffic.

…Read the full story